Both SCD1 and Δ6 desaturase activities are positively associated in animal models or humans with increased overall mortality [99,100] and cardiovascular mortality [99], obesity-related metabolic comorbidities [101], diabetes incidence [102], and hepatic fibrosis [103]. Here, SCD is linked to obesity disorder.